Cardiac transplantation, perindopril, and left ventricular hypertrophy in spontaneously hypertensive rats

Hypertension

Volumn 28, Issue 4, 1996, Pages 622-626

  Harrap, Stephen B ^a   O'Sullivan, Joseph B ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

angiotensin; bradykinin; hypertension, genetic; hypertrophy; transplantation

Indexed keywords

ANGIOTENSIN; BRADYKININ; BRADYKININ B2 RECEPTOR ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ICATIBANT; PERINDOPRIL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG MECHANISM; ENZYME INACTIVATION; ESSENTIAL HYPERTENSION; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE MASS; HEART TRANSPLANTATION; HEART WEIGHT; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SPONTANEOUSLY HYPERTENSIVE RAT;

EID: 0029845703     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.28.4.622     Document Type: Article

References (38)

1. Garg UC, Hassid A. Nitric oxide-generating vasodilators and·8-bromo-cyclic guanosine monophosphate inhibit mitogenesis and proliferation of cultured rat vascular smooth muscle cells. J Clin Invest. 1989;83:1774-1777.
2. Campbell-Boswell M, Robertson AL Jr. Effects of angiotensin II and vasopressin on human smooth muscle cells in vitro. Exp Mol Pathol. 1981;35:265-276.
3. Miyata S, Haneda T. Hypertrophic growth of cultured neonatal rat heart cells mediated by type 1 angiotensin II receptor. Am J Physiol. 1994;266:H2443-H2451.
4. Crabos M, Roth M, Hahn AW, Erne P. Characterization of angiotensin II receptors in cultured adult rat cardiac fibroblasts: coupling to signaling systems and gene expression. J Clin Invest. 1994;93:2372-2378.
5. Suzuki J, Matsubara H, Urakami M, Inada M. Rat angiotensin II (type 1A) receptor mRNA regulation and subtype expression in myocardial growth and hypertrophy. Circ Res. 1993;73:439-447.
6. Dahlof B, Pennert K, Hansson L. Regression of left ventricular hypertrophy: a meta-analysis. Clin Exp Hypertens A. 1992;14:173-180.
7. Fagard R, Lijnen P, Staessen J, Thijs L, Amery A. Mechanical and other factors relating to left ventricular hypertrophy. Blood Press Suppl. 1994;1:5-10.
8. Harrap SB, Dominiczak AF, Fraser R, Lever AF, Foy CJ, Watt GCM. Plasma angiotensin II, predisposition to hypertension and left ventricular size in healthy young adults. Circulation. 1996;93:1148-1154.
9. Campbell DJ, Kladis A, Duncan A-M. Effects of converting enzyme inhibition on angiotensin and bradykinin peptides. Hypertension. 1994;23:439-449.
10. Linz W, Weimer G, Schölkens BA. Bradykinin prevents left ventricular hypertrophy in rats. J Hypertens. 1993;11(suppl 5):S96-S97.
11. Linz W, Schölkens BA. A specific B2-bradykinin receptor antagonist HOE 140 abolishes the antihypertrophic effect of ramipril. Br J Pharmacol. 1992;105:771-772.
12. Ruzicka M, Yuan B, Leenen FH. Effects of enalapril versus losartan on regression of volume overload-induced cardiac hypertrophy in rats. Circulation. 1994;90:484-491.
13. Gohlke P, Stoll M, Lamberty V, Mattfield T, Mall G, van Even P, Martorana P, Unger Th. Cardiac and vascular effects of chronic angiotensin converting enzyme inhibition at subantihypertensive doses. J Hypertens. 1992;10(suppl 6):S141-S144.
14. Kapuscinski M, Charchar F, Innes B, Mitchell GA, Norman TL, Harrap SB. Nerve growth factor gene and hypertension in spontaneously hypertensive rats. J Hypertens. 1996;14:191-197.
15. Harrap SB, Wang BZ, MacLellan DG. Renal transplantation between male and female spontaneously hypertensive rats. Hypertension. 1992;15:431-434.
16. Ono K, Lindsey ES. Improved technique of heart transplantation in rats. J Thorac Cardiovasc Surg. 1968;57:225-232.
17. Korecky B, Masika M. Direct effect of increased hemodynamic load on cardiac mass. Circ Res. 1991;68:1174-1178.
18. O'Sullivan JB, Harrap SB. Resetting blood pressure in spontaneously hypertensive rats: the role of bradykinin. Hypertension. 1995; 25:162-165.
19. Gundersen HJG, Bagger P, Bendtsen TF, Evans SM, Korbo L, Marcussen N, Møler A, Nielsen K, Nyengaard JR, Pakkenberg B, Sørensen FB, Vesterby A, West MJ. The new stereological tools: dissector, fractionator, nucleator and point sampled intercepts and their use in pathological research and diagnosis. APMIS. 1998;96:857-881.
20. Harrap SB, Van der Merwe WM, Griffin SA, Macpherson F, Lever AF. Brief ACE inhibitor treatment in young spontaneously hypertensive rats reduces blood pressure long-term. Hypertension. 1990;16: 603-614.
21. Cramer DV, Qian S, Hamaha JB, Chapman FA, Estes LW, Starzl TE, Makowka L. Cardiac transplantation in the rat, I: the effect of histocompatibility differences on graft arteriosclerosis. Transplantation. 1989;47:414-419.
22. Geenen DL, Malhotra A, Buttrick PM, Scheuer J. Increased heart rate prevents the isomyosin shift after cardiac transplantation in the rat. Circ Res. 1992;70:554-558.
23. Klein I, Hong C. Effects of thyroid hormone on cardiac size and myosin content of the heterotopically transplanted rat heart. J Clin Invest. 1986;77:1694-1698.
24. Campbell DJ, Duncan A-M, Kladis A, Harrap SB. Angiotensin peptides in spontaneously hypertensive and normotensive Donryu rats. Hypertension. 1995;25:928-934.
25. Campbell DJ, Duncan A-M, Kladis A, Harrap SB. Increased levels of bradykinin and its metabolites in tissues of young spontaneously hypertensive rats. J Hypertens. 1995;13:739-746.
26. Golomb E, Abassi ZA, Cuda G, Stylianou M, Panchal VR, Trachewsky D, Keiser HR. Angiotensin II maintains, but does not mediate, isoproterenol-induced cardiac hypertrophy in rats. Am J Physiol. 1994;267:H1496-H1506.
27. Boer PH, Ruzicka M, Lear W, Harmsen E, Rosenthal J, Leenen FH. Stretch-mediated activation of cardiac renin gene. Am J Physiol. 1994;267:H1630-H1636.
28. Sadoshima J, Xu Y, Slayter HS, Izumo S. Autocrine release of angiotensin II mediates stretch-induced hypertrophy of cardiac myocytes in vitro. Cell. 1993;75:977-984.
29. Johnston CI. Franz Volhard Lecture. Renin-angiotensin system: a dual tissue and hormonal system for cardiovascular control. J Hypertens. 1992;10(suppl 7):S13-S26.
30. Geenen DL, Malhotra A, Scheuer J. Angiotensin II increases cardiac protein synthesis in adult rat heart. Am J Physiol. 1993;265:H238-H243.
31. Weimer G, Schölkens BA, Becker RHA, Busse R. Ramiprilat enhances endothelial autocoid formation by inhibiting breakdown of endothelium-derived bradykinin. Hypertension. 1991;18:558-563.
32. Gavras H. Angiotensin-converting enzyme inhibition and the heart. Hypertension. 1994;23:813-818.
33. Dietze G, Maeker E, Lodri C, Schifman R, Wicklmayr M, Geiger R, Fink E, Boettger I, Fritz H, Melinert H. Possible involvement of kinins in muscle energy metabolism. Adv Exp Med Biol. 1984; 167:63-71.
34. Scicli AG. Increases in cardiac kinins as a new mechanism to protect the heart. Hypertension. 1994;23:419-421.
35. Holtz J, Studer R, Reinecke H, Just H, Drexler H. Modulation of myocardial sarcoplasmic reticulum Ca(++)-ATPase in cardiac hypertrophy by angiotensin converting enzyme. Basic Res Cardiol. 1992;87(suppl 2):191-204.
36. Gohlke P, Linz W, Schölkens BA, Kuwer I, Bartenbach S, Schnell A, Unger T. Angiotensin-converting enzyme inhibition improves cardiac function: role of bradykinin. Hypertension. 1994;23:411-418.
37. Bao G, Gohlke P, Unger Th. Role of bradykinin in chronic antihypertensive actions of ramipril in different hypertension models. J Cardiovasc Pharmacol. 1992;20(suppl 9):S96-S99.
38. Rhaleb N-E, Yang X-P, Scicli AG, Carretero OA. Role of kinins and nitric oxide in the antihypertrophic effect of ramipril. Hypertension. 1994;23:865-868.